Skip to main content
TipRanks
Go Ultimate75% OFF

Paul Yanover Insider Profile

4 Followers

Paul Yanover, Director at Eterna Therapeutics, holds 5.26K shares in Eterna Therapeutics (Ticker: ERNA).

Paul Yanover's Trading History

ERNA
Eterna Therapeutics
Oct 03, 2017DirectorUninformative Buy―$8.84K
ERNA
Insider Shares: 5.26K (0.21%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Oct 03, 2017Uninformative Buy$0.00612$0.00―
Jul 05, 2017Uninformative Buy$0.00551$0.00―
May 26, 2016Informative Buy$10.35K65,000$0.15-13.20%
Jun 19, 2015Informative Buy$9.60K40,000$0.24-62.30%
Dec 18, 2012Uninformative Buy$0.00100,000$0.00―

You May Also Like

Paul Yanover insider profile FAQ

What is the percentage of profitable transactions made by Paul Yanover?
The percentage of profitable transactions made by Paul Yanover is 0%.
What is the average return per transaction made by Paul Yanover?
The average return per transaction made by Paul Yanover is -37.70%.
What stocks does Paul Yanover hold?
Paul Yanover holds: ERNA stocks.
What was Paul Yanover's most profitable transaction?
Paul Yanover’s most profitable transaction was an Informative Buy of ERNA stock on May 26, 2016. The return on the trade was -13.20%.
What is Paul Yanover's role in Eterna Therapeutics?
Paul Yanover's role in Eterna Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.